About Marc Yoskowitz
Marc Yoskowitz is a director at Keenova Therapeutics plc.
Form D filings name Marc Yoskowitz as a director at Endo.
Marc Yoskowitz reports to the SEC as a director or officer of 3 public companies, including Mereo BioPharma Group plc (MREO) and Hospira (HSP).
Marc Yoskowitz first appears on SEC filings in 2014.
Experience
This experience comes from SEC filings. The years are when the filings name Marc Yoskowitz in the role, so the role may have started earlier or lasted longer.
KP
Keenova Therapeutics plc
Director
2025 – 2026 · Public company
MP
Mereo BioPharma Group plc
Director
2024 – 2026 · Public company (MREO)
HI
Hospira Inc.
SVP, Strategy & Corporate Dev
2014 – 2015 · Public company (HSP)
Key Colleagues at Startups
The people Marc Yoskowitz works with at each company, as listed on that company's latest Form D.
Endo, Inc. · Form D/A, May 6, 2024
SH
Scott Hirsch
Director
PE
Paul Efron
Director
PH
Paul Herendeen
Director
PB
Patrick Barry
Executive Vice President; President, Global Commercial Operations
BC
Blaise Coleman
President; Chief Executive Officer and director
MM
Matthew Maletta
Executive Vice President; Chief Legal Officer; Secretary
SL
Sophia Langlois
Director
FR
Frank Raciti
Vice President; Controller; Chief Accounting Officer
MB
Mark Bradley
Executive Vice President; Chief Financial Officer and director
AP
Andy Pasternak
Director